MedPath

Preventive effect of maxijesic on rebound pai

Not Applicable
Recruiting
Conditions
Diseases of the musculoskeletal system and connective tissue
Registration Number
KCT0009479
Lead Sponsor
Samsung Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
78
Inclusion Criteria

Adults between 19 and 70 years of age
- Patients undergoing bone surgery of the hand or wrist with supraclavicular block
- American Society of Anesthesiologists Physical Status I, II, III

Exclusion Criteria

- Pregnant, lactating women
- Patients with serious coagulopathy (INR 1.5 or higher on the last blood coagulation test before surgery)
- Patients with unstable coronary artery disease, congestive heart failure, arrhythmia, and myocarditis
- Patients with cerebrovascular disease
- Patients with systemic infection or current infection in the area where supraclavicular block surgery will be performed (above the clavicle)
- Patients who did not understand this study and expressed their intention not to participate in the study
- Patients allergic to local anesthetics
- Patients contraindicated in the test drug (Maxijesic Injection)
? Patients with a history of hypersensitivity to study drug or its components
? Patients with active alcoholism
? Patients with gastrointestinal ulcers, gastrointestinal bleeding, or patients with a history of gastrointestinal ulcers or gastrointestinal bleeding
? Patients with severe blood abnormalities
? Patients with severe liver and kidney disorders
? Patients with severe cardiac dysfunction
? Patients with severe hypertension
? Patients with bronchial asthma or a history of it
? Patients who have or have a history of hypersensitivity, such as an allergic reaction, to aspirin or other non-steroidal anti-inflammatory drugs.
? Patients experiencing pain before and after coronary artery bypass surgery
? Pregnant women
? Patients taking the following drugs: barbiturates, tricyclic antidepressants
? Patients receiving high-dose methotrexate for anticancer therapy
- Others: autoimmune disease, history of drug hypersensitivity reaction, food allergy, chronic hives
- Patients with a serious psychiatric history that may affect patient evaluation
- Patients who failed supraclavicular block surgery

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rebound pain score
Secondary Outcome Measures
NameTimeMethod
pain scores;Worst pain ;The time of first analgesic request;opioid consumption;Patient satisfaction: analgesia ,fist nigh sleep;Adverse event: nausea and vomiting ,dizziness, respiratory depression, block related complication
© Copyright 2025. All Rights Reserved by MedPath